Skip to main content
. 2013 Mar 28;2013(3):CD002106. doi: 10.1002/14651858.CD002106.pub4

Comparison 7. Biosynthetic skin substitute (Biobrane) vs silver sulphadiazine.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Pain 2 106 Mean Difference (IV, Random, 95% CI) ‐1.63 [‐2.20, ‐1.06]
2 Need for surgery 1 50 Risk Ratio (M‐H, Fixed, 95% CI) 0.68 [0.21, 2.24]